cbdMD to buy Twinlab's brands, lifting revenue to $30M

What's the deal? cbdMDDealroom has a profile for this one. Try Dealroom → has signed a definitive agreement to acquire the operating assets and brands of TwinlabDealroom has a profile for this one. Try Dealroom →, including Twinlab, ReserveageDealroom has a profile for this one. Try Dealroom →, MetabolifeDealroom has a profile for this one. Try Dealroom →, and Alvita TeaDealroom has a profile for this one. Try Dealroom →. The deal runs through an assignment for the benefit of creditors (ABC) proceeding and is subject to court approval and customary closing conditions.

Who's who? cbdMD (NYSE American: YCBD) is a Charlotte-based consumer wellness company with roots in CBD and hemp. Twinlab, founded in 1968, is a legacy supplements and sports nutrition brand serving 50,000 retail outlets, including Vitamin ShopDealroom has a profile for this one. Try Dealroom → and GNCDealroom has a profile for this one. Try Dealroom →, plus a strong Amazon presence.

The numbers: Combined unaudited trailing 12-month revenue through June 2026 totals roughly $30 million, about 40% above cbdMD's standalone revenue for the same period. The company expects the added revenue to generate a positive contribution after transaction and integration costs, though it cautions the figure is illustrative only.

Why now? The deal is designed to cut cbdMD's revenue concentration in hemp and reduce risks tied to the shifting regulatory environment for hemp-derived products. For Twinlab, the ABC process offers what cbdMD calls "an orderly path forward" for legacy obligations.

What's the endgame? cbdMD is positioning itself as a multi-brand consumer wellness platform spanning supplements, sports nutrition, longevity, functional wellness, pet wellness, and hemp products. It expects its identity to evolve as the portfolio grows beyond CBD.

What they're saying: "Twinlab is the kind of brand equity that companies spend decades trying to build," said Ronan Kennedy, chief executive officer of cbdMD, adding that the brands and distribution channels are "highly complementary" to its existing operations.

The signal: The purchase reflects a broader push by wellness companies to consolidate heritage supplement brands under modern, marketing-driven platforms — and, for cbdMD, a hedge against regulatory uncertainty hanging over the hemp category.

Image credit: Twinlab